Overview
Dr. Ritesh Parajuli is a UCI Health medical oncologist who specializes in the management of patients with breast cancer.Parajuli earned his medical degree at Manipal College of Medical Sciences in Nepal, followed by a residency in internal medicine at Rosalind Franklin University of Medicine and Science in Chicago, Ill. He also completed a fellowship in hematology and oncology at the University of Miami Sylvester Comprehensive Cancer Center and Jackson Memorial Hospital, Miami, Fla.A translational researcher, Parajuli is focused on integrating liquid biopsy biomarkers that have prognostic and predictive implications for the management of breast cancer patients. These biomarkers include circulating tumor cells, circulating tumor DNA and circulating cancer-associated fibroblasts.Parajuli is co-leader of theChao Family Comprehensive Cancer Center’sbreast disease team, a multidisciplinary group that develops new clinical trial concepts and fosters the translation of discoveries into clinical treatments. He also is the principal investigator on a variety of breast cancer clinical trials, the author or co-author of dozens of published research papers, and recipient of many intramural and extramural research grants.Parajuli also serves as medical director of chemotherapy infusion.
Dr. Parajuli is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer.
Dr. Parajuli is board certified in American Board Of Internal Medicine - Medical Oncology. He is actively involved in clinical research, co-authoring 27 peer reviewed articles and participating in 12 clinical trials.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
101 The City Drive South, Building 23, Orange, CA 92868
19208 Jamboree Road, Irvine, CA 92612
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
12 Clinical Trials
UCI Health Chao Family Comprehensive Cancer Center
"Dr. Lauren C. Pinter-Brown is a board-certified, fellowship-trained UCI hematologist-oncologist who specializes in the diagnosis and treatment of patients with lymphomas.A nationally recognized expert, Pinter-Brown has a longstanding interest in malignant lymphoma, with a particular focus on T-cell and skin lymphomas. Her clinical interests also include antiphospholipid, B-cell lymphoma, Hodgkin's lymphoma, mycosis fungoides, non-Hodgkins lymphoma, stem-cell transplant and Waldenstrom's disease.She her medical degree at the David Geffen School of Medicine at UCLA Medical School, followed by an internship and residency in internal medicine at Harbor-UCLA Medical Center. She completed a fellowship in hematology and oncology at the Keck School of Medicine at USC.A prolific clinical investigator, Pinter-Brown has made important contributions to several clinical trials that led to approval of new drugs for the treatment of T-cell lymphoma. Her research focus is on optimizing treatment options for patients with lymphoma, especially cutaneous and T-cell lymphomas. Her primary goal is to care for patients through diagnosis, treatment and beyond and to ensure that they are able ""to live their best life.""". Dr. Pinter is highly rated in 30 conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Mycosis Fungoides, Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Transplant. Dr. Pinter is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine - Internal Medicine.
UCI Health Chao Family Comprehensive Cancer Center
Dr. Warren A. Chow is a board-certified UCI Health oncologist who specializes in melanoma and sarcomas. He serves as associate director for clinical services at the UCI Health Chao Family Comprehensive Cancer Center.He received his medical degree from Chicago Medical School at Rosalind Franklin University of Medicine and Science in North Chicago, Ill. He completed an internship and residency in internal medicine at Cedars-Sinai Medical Center in Los Angeles. Next he received fellowship training in medical oncology, hematology and bone marrow transplantation at the City of Hope in Duarte, Calif., where he served nearly 30 years as a clinician and researcher conducting bench-to-bedside studies in both bone and soft-tissue sarcomas.The recipient of numerous research grants from the National Cancer Institute, the U.S. Food and Drug Administration, the Melanoma Research Foundation and many others, Chow has been the principal investigator on more than three dozen clinical trials. He is the author of more than 80 publications and four book chapters, and he serves on the editorial boards of the journalsPLOS ONE,F1000 ResearchandScientific Reports (Nature). Dr. Chow is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Synovial Sarcoma, Adult Soft Tissue Sarcoma, Liposarcoma, and Chondrosarcoma. Dr. Chow is board certified in American Board Of Internal Medicine - Medical Oncology and American Board Of Internal Medicine - Internal Medicine.
UCI Health Chao Family Comprehensive Cancer Center
Dr. Stefan O. Ciurea is a UCI Health hematologist and director of the Hematopoietic Stem Cell Transplantation and Cellular Therapy Program at the Chao Family Comprehensive Cancer Center.Ciurea earned his medical degree at Grigore T. Popa University of Medicine and Pharmaceuticals in Iasi, Romania. He completed an internal medicine residency at UPMC Pinnacle Harrisburg in Harrisburg, Pa. He then completed a fellowship in hematology-oncology at University of Illinois at Chicago College of Medicine, followed by a fellowship in stem cell transplantation and cellular therapy at the University of Texas MD Anderson Cancer Center in Houston.Before joining the Chao Family Comprehensive Cancer Center to lead its program in hematopoietic stem cell transplantation and cellular therapy, Ciurea served for more than a decade on the faculty of the MD Anderson Cancer Center’s Department of Stem Cell Transplantation and Cellular Therapy.Ciurea is the author of more than 150 peer-reviewed publications and more than 10 book chapters. He also has served as principal investigator on multiple clinical trials, including investigator-initiated trials. He has been invited to speak at more than 50 meetings and conferences around the world, including as keynote speaker. Dr. Ciurea is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Ciurea is board certified in American Board Of Internal Medicine - Hematology.
Frequently Asked Questions about Dr. Ritesh Parajuli
How do I make an appointment with Dr. Ritesh Parajuli?
You can book an appointment with Dr. Ritesh Parajuli by calling their office at 714-456-8000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Ritesh Parajuli a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ritesh Parajuli is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Ritesh Parajuli specialize in?
While Dr. Ritesh Parajuli is a Hematology, they have specific expertise in Breast Cancer, Angiosarcoma, and Paget Disease of the Breast. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Ritesh Parajuli participate in research or clinical trials?
Yes. Dr. Ritesh Parajuli has published 27 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Ritesh Parajuli's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Ritesh Parajuli accept my insurance?
Dr. Ritesh Parajuli accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 714-456-8000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Parajuli isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Parajuli isDistinguished. Learn about Breast Cancer.
- Paget Disease of the BreastDr. Parajuli isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Inflammatory Breast CancerDr. Parajuli isAdvanced. Learn about Inflammatory Breast Cancer.
- Experienced
- AgranulocytosisDr. Parajuli isExperienced. Learn about Agranulocytosis.
- Breast Cancer in MenDr. Parajuli isExperienced. Learn about Breast Cancer in Men.
- Chromophobe Renal Cell CarcinomaDr. Parajuli isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Parajuli isExperienced. Learn about Clear Cell Sarcoma.
- Eccrine PorocarcinomaDr. Parajuli isExperienced. Learn about Eccrine Porocarcinoma.
- Familial Pancreatic CancerDr. Parajuli isExperienced. Learn about Familial Pancreatic Cancer.